Monitor the effectiveness date and final pricing of the IPO. Track progress on NRC license application (expected Q1 2027 submission) and Phase 1/2 CRISLA demonstration results. Cash runway is limited to early fiscal 2027 without additional financing.
How similar events traded
Executive Summary
LIS Technologies filed Amendment No. 1 to its S-1 registration statement for an IPO of 3,100,000 shares (up from 2,833,334 in the prior filing) at an assumed price of $5.00-$7.00 per share, with net proceeds estimated at $16.6 million. The company is an early-stage uranium enrichment developer using the patented CRISLA laser process, has generated no revenue to date, and has an accumulated deficit of $65.4 million as of July 31, 2026. Proceeds will fund R&D, business development, and working capital.
Key Financial Metrics
Key Facts
- IPO size increased to 3,100,000 shares from 2,833,334 shares in the prior S-1 filing
- Assumed IPO price range $5.00-$7.00 per share, midpoint $6.00
- Estimated net proceeds of $16.6 million (or $19.2 million with full over-allotment)
- No revenue generated since inception; accumulated deficit of $65,418,743 as of July 31, 2026
- Cash of $18.8 million as of July 31, 2026; cash burn $14.8 million in operating activities for nine months ended July 31, 2026
- Technology at TRL 4 (laboratory validated); commercialization targeted for 2030-2033
- DOE IDIQ contract participant; received $74,866 Air Force SBIR award
- State of Tennessee incentives package valued at over $200 million (not yet received)
- Related party NANO Nuclear invested $2 million; Joint Collaboration Agreement in place
- CEO Jay Jiang Yu beneficially owns ~25.95% of shares pre-offering
Financial Impact
IPO net proceeds of $16.6 million; accumulated deficit of $65.4 million; cash burn $14.8 million in 9 months
Risk Factors
- Pre-revenue, early-stage company with unproven technology at commercial scale
- Requires substantial additional capital (estimated $1.38 billion for LEU-3 Facility)
- NRC licensing process is complex, lengthy, and uncertain
- Heavy reliance on related party NANO Nuclear for feedstock and collaboration
- CEO has significant ownership and potential conflicts of interest with NANO Nuclear
- No active trading market for shares; stock price may be volatile
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001493152-26-050287 |
| Exhibit: ex107.htm | 0001493152-26-050287 |
| Exhibit: ex23-1.htm | 0001493152-26-050287 |
| Document: 0001493152-26-050287-index-headers.html | 0001493152-26-050287 |
| Document: 0001493152-26-050287-index.html | 0001493152-26-050287 |
| Document: 0001493152-26-050287.txt | 0001493152-26-050287 |
Track record
2 reports on LIS
Filters
- Nov 17, 20264d ago S-1/A Neutral 5/10 No price data
- Nov 5, 202616d ago S-1/A Neutral 5/10 Viewing No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers